CLDX
Price
$22.78
Change
-$0.83 (-3.52%)
Updated
Sep 4 closing price
Capitalization
1.51B
61 days until earnings call
FENC
Price
$9.18
Change
+$0.32 (+3.61%)
Updated
Sep 4 closing price
Capitalization
250.74M
62 days until earnings call
Interact to see
Advertisement

CLDX vs FENC

Header iconCLDX vs FENC Comparison
Open Charts CLDX vs FENCBanner chart's image
Celldex Therapeutics
Price$22.78
Change-$0.83 (-3.52%)
Volume$1.44M
Capitalization1.51B
Fennec Pharmaceuticals
Price$9.18
Change+$0.32 (+3.61%)
Volume$45.54K
Capitalization250.74M
CLDX vs FENC Comparison Chart in %
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. FENC commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and FENC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (CLDX: $22.78 vs. FENC: $9.18)
Brand notoriety: CLDX and FENC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 118% vs. FENC: 74%
Market capitalization -- CLDX: $1.51B vs. FENC: $250.74M
CLDX [@Biotechnology] is valued at $1.51B. FENC’s [@Biotechnology] market capitalization is $250.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileFENC’s FA Score has 0 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • FENC’s FA Score: 0 green, 5 red.
According to our system of comparison, FENC is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 5 TA indicator(s) are bullish while FENC’s TA Score has 6 bullish TA indicator(s).

  • CLDX’s TA Score: 5 bullish, 5 bearish.
  • FENC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, FENC is a better buy in the short-term than CLDX.

Price Growth

CLDX (@Biotechnology) experienced а +1.79% price change this week, while FENC (@Biotechnology) price change was +3.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +14.49%, and the average quarterly price growth was +29.01%.

Reported Earning Dates

CLDX is expected to report earnings on Nov 05, 2025.

FENC is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.51B) has a higher market cap than FENC($251M). FENC YTD gains are higher at: 45.253 vs. CLDX (-9.854). FENC has higher annual earnings (EBITDA): -8.39M vs. CLDX (-231.4M). CLDX has more cash in the bank: 630M vs. FENC (18.7M). CLDX has less debt than FENC: CLDX (3.03M) vs FENC (19.4M). FENC has higher revenues than CLDX: FENC (33.3M) vs CLDX (5.79M).
CLDXFENCCLDX / FENC
Capitalization1.51B251M603%
EBITDA-231.4M-8.39M2,757%
Gain YTD-9.85445.253-22%
P/E RatioN/A64.14-
Revenue5.79M33.3M17%
Total Cash630M18.7M3,369%
Total Debt3.03M19.4M16%
FUNDAMENTALS RATINGS
CLDX vs FENC: Fundamental Ratings
CLDX
FENC
OUTLOOK RATING
1..100
576
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
7796
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
5143
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLDX's Valuation (58) in the Biotechnology industry is in the same range as FENC (89). This means that CLDX’s stock grew similarly to FENC’s over the last 12 months.

CLDX's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as FENC (96). This means that CLDX’s stock grew similarly to FENC’s over the last 12 months.

CLDX's SMR Rating (96) in the Biotechnology industry is in the same range as FENC (100). This means that CLDX’s stock grew similarly to FENC’s over the last 12 months.

FENC's Price Growth Rating (43) in the Biotechnology industry is in the same range as CLDX (51). This means that FENC’s stock grew similarly to CLDX’s over the last 12 months.

FENC's P/E Growth Rating (97) in the Biotechnology industry is in the same range as CLDX (100). This means that FENC’s stock grew similarly to CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLDXFENC
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 14 days ago
82%
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 18 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVPX16.10N/A
N/A
Lord Abbett Fundamental Equity P
PLSAX31.24N/A
N/A
Principal Large Cap S&P 500 Index A
FFTYX16.49N/A
N/A
AB Sustainable US Thematic Advisor
SECAX11.72N/A
N/A
SEI Small Cap II A (SIIT)
MRCGX29.95N/A
N/A
Meridian Growth C

FENC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FENC has been loosely correlated with IDYA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FENC jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FENC
1D Price
Change %
FENC100%
+3.61%
IDYA - FENC
46%
Loosely correlated
+0.27%
CLDX - FENC
44%
Loosely correlated
-3.52%
BEAM - FENC
43%
Loosely correlated
-1.17%
DNLI - FENC
41%
Loosely correlated
-3.40%
CGEM - FENC
41%
Loosely correlated
-10.49%
More